OGEN · Oragenics Inc

Substantial doubt about the company's ability to continue as a going concern.

“Considering our recurring losses, accumulated deficit, and negative cash flows, the report of our independent registered public accounting firm on our consolidated financial statements for the year ended December 31, 2025, included an explanatory paragraph raising substantial doubt about our ability to continue as a going concern. ... These factors raise substantial doubt regarding our ability to continue as a going concern. We plan to pursue additional financing to mitigate liquidity risk; however, substantial doubt about our ability to continue as a going concern remains unless and until we obtain sufficient capital to fund operations beyond the current planning horizon. ... Based on these factors, there is substantial doubt about the Company's ability to continue as a going concern.”